MRY Cardiac Supplies Limited Micro entities accounts

MRY Cardiac Supplies Limited Micro entities accounts

MRY CARDIAC SUPPLIES LIMITED - Company Information

Print Friendly Version

false false false false false false false false false true false false true true true true true No description of principal activity 2016-05-01 Sage Accounts Production Advanced 2017 - FRS xbrli:pure xbrli:shares iso4217:GBP 06633331 2016-05-01 2017-04-30 06633331 2017-04-30 06633331 2016-04-30 06633331 bus:LeadAgentIfApplicable 2016-05-01 2017-04-30 06633331 bus:Director1 2016-05-01 2017-04-30 06633331 core:WithinOneYear 2017-04-30 06633331 core:WithinOneYear 2016-04-30 06633331 core:RestatedAmount 2016-04-30 06633331 bus:Micro-entities 2016-05-01 2017-04-30 06633331 bus:AuditExemptWithAccountantsReport 2016-05-01 2017-04-30 06633331 bus:FullAccounts 2016-05-01 2017-04-30 06633331 bus:SmallCompaniesRegimeForAccounts 2016-05-01 2017-04-30 06633331 bus:PrivateLimitedCompanyLtd 2016-05-01 2017-04-30
COMPANY REGISTRATION NUMBER: 06633331
MRY Cardiac Supplies Limited
Unaudited financial statements
30 April 2017
BROOKS CARLING ACCOUNTANTS LIMITED
Reporting accountants
Highview House, 1st Floor,
Tattenham Crescent
Epsom
Surrey
KT18 5QJ
MRY Cardiac Supplies Limited
Financial statements
Year ended 30 April 2017
Contents
Pages
Reporting accountants report to the board of directors on the preparation of the unaudited statutory financial statements
1
Statement of financial position and the notes to the financial statements
2 to 3
MRY Cardiac Supplies Limited
Reporting accountants report to the board of directors on the preparation of the unaudited statutory financial statements of MRY Cardiac Supplies Limited
Year ended 30 April 2017
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of MRY Cardiac Supplies Limited for the year ended 30 April 2017, which comprise the statement of financial position and the notes to the financial statements from the company's accounting records and from information and explanations you have given us. As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements. This report is made solely to the Board of Directors of MRY Cardiac Supplies Limited, as a body, in accordance with the terms of our engagement letter dated 7 November 2017. Our work has been undertaken solely to prepare for your approval the financial statements of MRY Cardiac Supplies Limited and state those matters that we have agreed to state you, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than MRY Cardiac Supplies Limited and its Board of Directors, as a body, for our work or for this report.
It is your duty to ensure that MRY Cardiac Supplies Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of MRY Cardiac Supplies Limited. You consider that MRY Cardiac Supplies Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the financial statements of MRY Cardiac Supplies Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
BROOKS CARLING ACCOUNTANTS LIMITED Reporting accountants
Highview House, 1st Floor, Tattenham Crescent Epsom Surrey KT18 5QJ
9 January 2018
MRY Cardiac Supplies Limited
Statement of financial position
30 April 2017
2017
2016
£
£
£
Fixed assets
302,264
362,919
---------
---------
Current assets
349,033
572,787
Creditors: amounts falling due within one year
220,362
271,502
---------
---------
Net current assets
128,671
301,285
---------
---------
Total assets less current liabilities
430,935
664,204
Accruals and deferred income
17,495
17,985
---------
---------
413,440
646,219
---------
---------
Capital and reserves
413,440
646,219
---------
---------
Notes to the financial statements
1. Directors' advances, credits and guarantees
During the year, MRY Cardiac Supplies Limited gave Dr P Roberts, a director and shareholder of the company, an interest free loan of £139,637 (2016 : £115,900). Dr P Roberts repaid £156,000 (2016 : £152,045) of which £156,000 (2016 : £130,000) was in respect of dividend distribution during the year, leaving a balance due from MRY Cardiac Supplies Limited , at the year end, of £76,145 (2016 : £59,782). During the year, MRY Cardiac Supplies Limited gave Dr J Morgan, a director and shareholder of the company, an interest free loan of £113,104 (2016 : £115,900). Dr J Morgan repaid £113,882 (2016 : £149,334) of which £100,000 (2016 : £130,000) was in respect of dividend distribution during the year, leaving a balance due from MRY Cardiac Supplies Limited , at the year end, of £48,125 (2016 : £47,348). During the year, MRY Cardiac Supplies Limited gave Dr A Yue, a director and shareholder of the company, an interest free loan of £95,019 (2016 : £95,200). Dr A Yue repaid £106,000 (2016 : £65,000) of which £106,000 (2016 : £65,000) was in respect of dividend distribution during the year, leaving a balance due from MRY Cardiac Supplies Limited , at the year end, of £40,994 (2016 : £30,013). During the year, MRY Cardiac Supplies Limited gave Dr J R Paisey, a director and shareholder of the company, an interest free loan of £25,499 (2016 : £nil). Dr J R Paisey repaid £28,000 (2016 : £nil) of which £28,000 (2016 : £nil) was in respect of dividend distribution during the year, leaving a balance due from MRY Cardiac Supplies Limited , at the year end, of £2,501 (2016 : £nil). As at the year end, Dr P Roberts and Dr A Yue hold 40% each with Dr J R Paisey holding the remaining 20%, of MRY Cardiac Supplies Limited issued share capital. Dr J Morgan had held 40% of the shares during the year which were fully disposed of by the year end.
For the year ending 30 April 2017 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 9 January 2018 , and are signed on behalf of the board by:
Dr P R Roberts
Director
Company registration number: 06633331
The company is a private company limited by shares, registered in England and Wales.